Breaking News, Financial News

Financial Report: Kendle 3Q

Early Stage revenue was $10.8 million (-4%) and YTD was $27.2 million (+7%).

Kendle 3Q09

3Q Revenues: $133.8 million (-26%)

3Q Earnings:
$8.8 million (-6%)

YTD Revenues:
$421.0 million (-19%)

YTD Earnings: $12.9 million (-35%)

Comments: Early Stage revenue was $10.8 million (-4%) and YTD was $27.2 million (+7%). Late Stage revenue was down 17% to $91.5 million in the quarter and down 14% to $284.7 million YTD. New business awards for the quarter totaled $137.2 million, up from $132 million in 2Q09. Contract cancellations for the quarter were $53.8 million or 6% of the company’s backlog at June 30, 2009.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters